Department of Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
J Nucl Med. 2011 Jul;52(7):1020-7. doi: 10.2967/jnumed.111.087452. Epub 2011 Jun 16.
Formation and progression of atherosclerotic plaque is a dynamic and complex process involving various pathophysiologic steps including inflammation and calcification. The purpose of this study was to compare macrophage activity as determined by (18)F-FDG PET and ongoing mineral deposition as measured by (18)F-sodium fluoride PET in atherosclerotic plaque and to correlate these findings with calcified plaque burden as assessed by CT.
Forty-five patients were examined by whole-body (18)F-FDG PET, (18)F-sodium fluoride PET, and CT. Tracer uptake in various arterial segments was analyzed both qualitatively and semiquantitatively by measuring the blood-pool-corrected standardized uptake value (target-to-background ratio [TBR]). The pattern of tracer uptake in atherosclerotic lesions was compared after color-coded multistudy image fusion of PET and CT studies. The Fisher exact test and the Spearman correlation coefficient r(s) were used for statistical analysis of image-based results and cardiovascular risk factors. Intra- and interrater reproducibility were evaluated using the Cohen κ.
(18)F-sodium fluoride uptake was observed at 105 sites in 27 (60%) of the 45 study patients, and mean TBR was 2.3 ± 0.7. (18)F-FDG uptake was seen at 124 sites in 34 (75.6%) patients, and mean TBR was 1.5 ± 0.3. Calcified atherosclerotic lesions were observed at 503 sites in 34 (75.6%) patients. Eighty-one (77.1%) of the 105 lesions with marked (18)F-sodium fluoride uptake and only 18 (14.5%) of the 124 lesions with (18)F-FDG accumulation were colocalized with arterial calcification. Coincident uptake of both (18)F-sodium fluoride and (18)F-FDG was observed in only 14 (6.5%) of the 215 arterial lesions with radiotracer accumulation.
PET/CT with (18)F-FDG and (18)F-sodium fluoride may allow evaluation of distinct pathophysiologic processes in atherosclerotic lesions and might provide information on the complex interactions involved in formation and progression of atherosclerotic plaque.
比较动脉粥样硬化斑块中通过 (18)F-FDG PET 测定的巨噬细胞活性与通过 (18)F-氟化钠 PET 测定的持续矿物质沉积,并将这些发现与 CT 评估的钙化斑块负担相关联。
对 45 例患者进行全身 (18)F-FDG PET、(18)F-氟化钠 PET 和 CT 检查。通过测量血池校正标准化摄取值(靶-背景比 [TBR]),对各动脉段的示踪剂摄取进行定性和半定量分析。对 PET 和 CT 研究的彩色多研究图像融合后,比较动脉粥样硬化病变中示踪剂摄取的模式。Fisher 确切检验和 Spearman 相关系数 r(s) 用于基于图像的结果和心血管危险因素的统计分析。使用 Cohen κ 评估组内和组间的可重复性。
在 45 例研究患者中的 27 例(60%)的 105 个部位观察到 (18)F-氟化钠摄取,平均 TBR 为 2.3 ± 0.7。在 34 例(75.6%)患者中的 124 个部位观察到 (18)F-FDG 摄取,平均 TBR 为 1.5 ± 0.3。在 34 例(75.6%)患者中观察到 503 个钙化动脉粥样硬化病变。在 105 个具有明显(18)F-氟化钠摄取的病变中,有 81 个(77.1%)与动脉钙化相重合,而在 124 个具有(18)F-FDG 积聚的病变中,只有 18 个(14.5%)与动脉钙化相重合。在 215 个具有放射性示踪剂积聚的动脉病变中,仅观察到 14 个(6.5%)同时摄取 (18)F-氟化钠和 (18)F-FDG。
用 (18)F-FDG 和 (18)F-氟化钠进行 PET/CT 检查可能可以评估动脉粥样硬化斑块中不同的病理生理过程,并提供有关动脉粥样硬化斑块形成和进展中复杂相互作用的信息。